BCL2 and non-small cell lung carcinoma: Treatment with licochalcone A decreased the protein level of survivin, but not Bcl‐2, Bcl‐xL or Mcl‐1, robustly in either WT or mutant EGFR‐expressing NSCLC cells (Figure 4F).